Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics is segmented on the basis of its use for indications such as oncology, cardiovascular conditions, central nervous system indications, inflammation and virology. Oncology is the highest revenue generating segment, as majority of the companion diagnostics have been developed for detection of various cancer biomarkers. The key driver for this market is an increase in research and development of targeted drugs, which require a corresponding companion diagnostic. Market Analysis and Insights: Global Companion Diagnostic Technologies Market The global Companion Diagnostic Technologies market size is projected to reach US$ 6057.7 million by 2027, from US$ 2771.3 million in 2020, at a CAGR of 11.3% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Diagnostic Technologies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Diagnostic Technologies market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Diagnostic Technologies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Diagnostic Technologies market. Global Companion Diagnostic Technologies Scope and Market Size Companion Diagnostic Technologies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type Immunohistochemistry Molecular Diagnostics Segment by Application Oncology Cardiovascular Central Nervous System Auto immune & Inflammation Virology Others By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company Dako (Agilent Technologies) Qiagen Roche Abbott Laboratories Thermo Fisher Scientific bioMerieux Myriad Genetics Resonance Health Ltd. Leica Microsystems Danaher
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Companion Diagnostic Technologies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Immunohistochemistry 1.2.3 Molecular Diagnostics 1.3 Market by Application 1.3.1 Global Companion Diagnostic Technologies Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 O
